Bioqual, Inc. Share Price Other OTC
Equities
BIOQ
US09065J1016
Biotechnology & Medical Research
Sales 2022 | 6.62Cr 551.57Cr | Sales 2023 | 6.27Cr 522.5Cr | Capitalization | 6.8Cr 566.79Cr |
---|---|---|---|---|---|
Net income 2022 | 50L 42Cr | Net income 2023 | - 0 | EV / Sales 2022 | 1.2 x |
Net Debt 2022 | 1.65Cr 137.92Cr | Net Debt 2023 | 1.13Cr 94Cr | EV / Sales 2023 | 1.27 x |
P/E ratio 2022 |
11.9
x | P/E ratio 2023 |
81.7
x | Employees | - |
Yield 2022 |
1.43% | Yield 2023 |
0.66% | Free-Float | 55.92% |
Managers | Title | Age | Since |
---|---|---|---|
Mark G. Lewis
CEO | Chief Executive Officer | 69 | 01/03/01 |
Charles C Kirk
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 09/22/09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 87 | 01/15/01 | |
Mark G. Lewis
CEO | Chief Executive Officer | 69 | 01/03/01 |
Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+29.26% | 4.92TCr | |
+1.08% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.67% | 2.61TCr | |
-22.93% | 1.87TCr | |
+8.25% | 1.33TCr | |
+32.32% | 1.23TCr | |
-0.69% | 1.2TCr |